Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Iman Badr Ibrahim1, Poul Videbech2, Sune Puggaard Vogt Straszek3,4

  • 1Afdeling for Nuklearmedicin, Københavns Universitetshospital - Herlev Hospital.

Ugeskrift for Laeger
|August 24, 2023
PubMed
Summary
This summary is machine-generated.

Psychedelics like psilocybin and MDMA show promise for treating depression and PTSD. While effective in trials, further research is needed to confirm long-term safety and efficacy.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methodological limitations of anxiety screening tools used in migraine studies -a narrative review.

Cephalalgia : an international journal of headache·2026
Same author

Acute SARS-CoV-2 infection and self-reported post-acute cognitive dysfunctions from the Danish EFTER-COVID survey.

Communications medicine·2026
Same author

Feasibility of a Supportive Cancer Care Intervention for Patients With Pre-Existing Severe Mental Disorders-The CASEMED Model.

Psycho-oncology·2026
Same author

Quality in specialist palliative care for patients with pre-existing severe mental disorders: A retrospective cohort study.

Palliative medicine·2026
Same author

Brain reserve in memory regions is associated with the preservation of autobiographical memories after electroconvulsive therapy.

Frontiers in psychiatry·2025
Same author

The Impact of Preexisting Severe Mental Disorders on Cancer Mortality: A Systematic Review and Meta-Analysis.

Acta psychiatrica Scandinavica·2025
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Depression and Post-Traumatic Stress Disorder (PTSD) are significant global health challenges.
  • Current treatments for depression and PTSD have limitations, necessitating novel therapeutic approaches.
  • Psychedelic compounds are emerging as potential therapeutic agents for psychiatric disorders.

Conclusions:

  • Psychedelics represent a promising therapeutic avenue for depression and PTSD.
  • Further large-scale studies are essential to establish the long-term safety and efficacy of these compounds.
  • Controlled research settings are crucial for safe administration and monitoring.